A Case Report: Metastasis of Clear Cell Ovarian Cancer in Morrison’s Pouch as Differential Diagnosis to Exophytic Kidney Tumor
- 1 Department of Urology, Regional Hospital West, Holstebro, Denmark
- 2 Department of Urology, Aarhus University Hospital, Aarhus, Denmark
Abstract
A 62-year-old woman with a history of curatively treated mucinous ovarian cancer, presented with dyspnea, anorexia and right-upper-quadrant pain at consultation with her general practitioner. A CT scan revealed several lymph node metastases in lungs and abdomen as well as a tumor in Morrison’s pouch and biopsy revealed renal cell carcinoma. Therefore, she was referred to Department of Urology. The multidisciplinary team could not immediately reject that there could be an exophytic tumor in the right kidney but discrepancy between histology and imaging, led to several biopsies including laparoscopic procedure. Re-examination of the primary ovarian cancer showed that one percent was classified as clear cell carcinoma. The final diagnose was metastatic clear cell ovarian carcinoma. The patient was terminal and suffered of cachexia and pleural effusion. The patient deceased four months after first consultation.
- Ovary, EUCAN Cancer Factsheets. http://eco.iarc.fr/eucan/CancerOne.aspx?Cancer=27&Gender=2#block-map-f
- Kidney, EUCAN Cancer Factsheets. http://eco.iarc.fr/eucan/CancerOne.aspx?Cancer=27&Gender=2
- DGCG (2016) Clinical Guideline for Visitation, Diagnostik, Treatment and Control of Epithelian Ovary-, Tuba- and Primary Peritoneal Cancer including Borderline Tumors. Udgave.
- Jacobs, I.J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J.K., et al. (2016) Ovarian Cancer Screening and Mortality in the UK. Lancet, 387, 945-956. https://doi.org/10.1016/S0140-6736(15)01224-6
- Ozga, M., Aghajanian, C., Myers-Virtue, S., McDonnell, G., Jhanwar, S., Hichenberg, S., et al. (2015) A Systematic Review of Ovarian Cancer and Fear of Recurrence. Palliative & Supportive Care, 13, 1771-1780. https://doi.org/10.1017/S1478951515000127
- Ushijima, K. (2010) Treatment for Recurrent Ovarian Cancer—At First Relapse. Journal of Oncology, 2010, Article ID: 497429. https://doi.org/10.1155/2010/497429
- Ljungberg, B., Cowan, N.C., Hanbury, D.C., et al. (2010) EAU Guidelines on Renal Cell Carcinoma: The 2010 Update. European Urology, 58, 398-406. https://doi.org/10.1016/j.eururo.2010.06.032
- Sugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I. and Taguchi, K. (2000) Clinical Characteristics of Clear Cell Carcinoma. A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum Based. Cancer, 88, 2584-2589. https://doi.org/10.1002/1097-0142(20000601)88:11 3.0.CO;2-5
- Heintz, A.P., Odicino, F., Maisonneuve, P., et al. (2006) FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynecology & Obstetrics, 95, S161-S192. https://doi.org/10.1016/S0020-7292(06)60033-7
- Mentrikoski, M.J., Wendroth, S.M. and Wick, M.R. (2014) Immunohistochemical Distinction of Renal Cell Carcinoma from Other Carcinomas with Clear-Cell Histomorphology: Utility of CD10 and CA-125 in Addition to PAX-2, PAX-8, RCCma, and Adipophilin. Applied Immunohistochemistry & Molecular Morphology, 22, 635-641. https://doi.org/10.1097/PAI.0000000000000004
- Lengyel, E. (2010) Ovarian Cancer Development and Metastasis. American Journal of Pathology, 177, 1053-1064. https://doi.org/10.2353/ajpath.2010.100105